ArticleFrontiers in oncology2026

Metabolic syndrome as an independent predictor of response and survival in locally advanced gastric cancer treated with neoadjuvant immunochemotherapy.

Fang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.